Displaying 73 - 84 of 452
Cirrhosis & Complications
4

Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024

View
Cirrhosis & Complications
4

Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024

View
Cirrhosis & Complications
4

Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
6

Mirum: PSC and IBAT Inhibitors: Can We Apply Our Paediatric Experience in Adult Hepatology? - EASL Congress 2024

View
Cirrhosis & Complications
4

Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024

View
General Hepatology
5

Takeda: A tale of two specialties in AATD: An interactive discussion of case studies - EASL Congress 2024

View
General Hepatology
5

Takeda: A tale of two specialties in AATD: An interactive discussion of case studies - EASL Congress 2024

View
General Hepatology
5

Takeda: A tale of two specialties in AATD: An interactive discussion of case studies - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
General Hepatology
5

Takeda: A tale of two specialties in AATD: An interactive discussion of case studies - EASL Congress 2024

View
General Hepatology
5

Takeda: A tale of two specialties in AATD: An interactive discussion of case studies - EASL Congress 2024

View
Displaying 73 - 84 of 452